标题
Albumin: An Emerging Opportunity in Drug Delivery
作者
关键词
-
出版物
BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-18
DOI
10.1007/s12257-019-0512-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Liquid Formulation of a Long-acting Erythropoietin Conjugate
- (2020) Hyung-Kyu Lim et al. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
- A new class of recombinant human albumin with multiple surface thiols exhibit stable conjugation, and enhanced FcRn binding and blood circulation
- (2019) Karen Kræmmer Schelde et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Spotlight on aldoxorubicin (INNO-206) and its potential in the treatment of soft tissue sarcomas: evidence to date
- (2019) Lee D Cranmer OncoTargets and Therapy
- Mini-review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders
- (2019) Marie Brandt et al. NUCLEAR MEDICINE AND BIOLOGY
- Structural basis of drug recognition by human serum albumin
- (2019) Loris Leboffe et al. CURRENT MEDICINAL CHEMISTRY
- Strategies for the production of long-acting therapeutics and efficient drug delivery for cancer treatment
- (2019) Alanod D. AlQahtani et al. BIOMEDICINE & PHARMACOTHERAPY
- The Neonatal Fc Receptor (FcRn): A Misnomer?
- (2019) Michal Pyzik et al. Frontiers in Immunology
- An effective and safe treatment strategy for rheumatoid arthritis based on human serum albumin and Kolliphor® HS 15
- (2019) Ting Gong et al. Nanomedicine
- Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy
- (2019) Koichi Sasaki et al. Science Advances
- Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction
- (2019) Anne S. De Groot et al. Scientific Reports
- Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo
- (2018) Yi Chen et al. BIOCONJUGATE CHEMISTRY
- Therapeutic peptides: Historical perspectives, current development trends, and future directions
- (2018) Jolene L. Lau et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Roles of Albumin-binding Proteins in Cancer Progression and Biomimetic Targeted Drug Delivery
- (2018) Yongzhuo Huang et al. CHEMBIOCHEM
- Potential of siRNA-albumin complex against cancer
- (2018) Na Liu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
- (2018) Jincheng Yang et al. DRUG DELIVERY
- Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients
- (2018) Montserrat Costa et al. JOURNAL OF ALZHEIMERS DISEASE
- Applications of nanoparticle systems in drug delivery technology
- (2018) Syed A.A. Rizvi et al. SAUDI PHARMACEUTICAL JOURNAL
- High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis
- (2018) Yoonhyuk Jang et al. Scientific Reports
- Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased in vivo anti-tumor efficacy
- (2018) Junnan Feng et al. Theranostics
- Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics
- (2018) Chunpeng Yang et al. Frontiers in Immunology
- Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma
- (2018) Chunhui Ruan et al. Acta Pharmaceutica Sinica B
- Harnessing albumin as a carrier for cancer therapies
- (2018) Ella N. Hoogenboezem et al. ADVANCED DRUG DELIVERY REVIEWS
- Recent updates on GLP-1 agonists: Current advancements & challenges
- (2018) Dilip Sharma et al. BIOMEDICINE & PHARMACOTHERAPY
- Cellular recycling-driven in vivo half-life extension using recombinant albumin fusions tuned for neonatal Fc receptor (FcRn) engagement
- (2018) Maja Thim Larsen et al. JOURNAL OF CONTROLLED RELEASE
- Human serum albumin and p53-derived peptide fusion protein promotes cytotoxicity irrespective of p53 status in cancer cells
- (2018) Ivana Roscoe et al. MOLECULAR PHARMACEUTICS
- Investigation of HSA as a biocompatible coating material for arsenic trioxide nanoparticles
- (2018) Maneka Hoonjan et al. Nanoscale
- HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment
- (2018) Yuzhou Shen et al. Drug Design Development and Therapy
- Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy
- (2018) Wei-Jie Cheng et al. International Journal of Nanomedicine
- Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy
- (2018) Yating Sun et al. International Journal of Nanomedicine
- The association between albumin-dNLR score and disease activity in patients with rheumatoid arthritis
- (2018) Shuaishuai Chen et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Hypoalbuminemia: Pathogenesis and Clinical Significance
- (2018) Peter B. Soeters et al. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
- The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies
- (2018) Mattia Ferrarese et al. THROMBOSIS RESEARCH
- Antidiabetic Effect of Abextide, a Long-Acting Exendin-4 Analogue in Cynomolgus Monkeys
- (2018) Gang Niu et al. Advanced Healthcare Materials
- Preparation, characterization and in vitro activity of a docetaxel–albumin conjugate
- (2018) Jing Gao et al. BIOORGANIC CHEMISTRY
- Molecular Insights into Human Serum Albumin as a Receptor of Amyloid-β in the Extracellular Region
- (2017) Tae Su Choi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate
- (2017) H. Kaspar Binz et al. mAbs
- Half-life extension using serum albumin-binding DARPin® domains
- (2017) Daniel Steiner et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Generation of therapeutic protein variants with the human serum albumin binding capacity via site-specific fatty acid conjugation
- (2017) Jinhwan Cho et al. Scientific Reports
- Site-Specific Albumination as an Alternative to PEGylation for the Enhanced Serum Half-Life in Vivo
- (2016) Byungseop Yang et al. BIOMACROMOLECULES
- Albumin-binding caspase-cleavable prodrug that is selectively activated in radiation exposed local tumor
- (2016) Seung Woo Chung et al. BIOMATERIALS
- Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy
- (2016) Zhibo Liu et al. CHEMICAL SOCIETY REVIEWS
- Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation
- (2016) Søren B. van Witteloostuijn et al. ChemMedChem
- Coagulation Factor IX (Recombinant), Albumin Fusion Protein (Albutrepenonacog Alfa; Idelvion®): A Review of Its Use in Haemophilia B
- (2016) Katherine A. Lyseng-Williamson DRUGS
- Half-life extended biotherapeutics
- (2016) Roland E. Kontermann EXPERT OPINION ON BIOLOGICAL THERAPY
- Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer’s Disease Amyloid-β Peptides: Protective Effect of Human Serum Albumin
- (2016) Marta Domínguez-Prieto et al. JOURNAL OF ALZHEIMERS DISEASE
- Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding
- (2016) Haojun Chen et al. Theranostics
- Efficient expression of glucagon-like peptide-1 analogue with human serum albumin fusion protein in Pichia pastoris using the glyceraldehyde-3-phosphate dehydrogenase promoter
- (2015) Kai Qian et al. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
- Site-specific albumination of a therapeutic protein with multi-subunit to prolong activity in vivo
- (2015) Sung In Lim et al. JOURNAL OF CONTROLLED RELEASE
- Human Serum Albumin-TRAIL Conjugate for the Treatment of Rheumatoid Arthritis
- (2014) Hyeong Jun Byeon et al. BIOCONJUGATE CHEMISTRY
- Engineering an aglycosylated Fc variant for enhanced FcγRI engagement and pH-dependent human FcRn binding
- (2014) Sang Taek Jung et al. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
- Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor (FcRn) Binding
- (2014) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Unraveling the mysteries of serum albumin—more than just a serum protein
- (2014) Angelica M. Merlot et al. Frontiers in Physiology
- Orthogonal Assembly of a Designed Ankyrin Repeat Protein–Cytotoxin Conjugate with a Clickable Serum Albumin Module for Half-Life Extension
- (2013) Manuel Simon et al. BIOCONJUGATE CHEMISTRY
- Site-specific fatty acid-conjugation to prolong protein half-life in vivo
- (2013) Sung In Lim et al. JOURNAL OF CONTROLLED RELEASE
- PEGylated drugs in rheumatology--why develop them and do they work?
- (2013) T. McDonnell et al. RHEUMATOLOGY
- Fusion protein linkers: Property, design and functionality
- (2012) Xiaoying Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
- (2012) A. A. Manzoor et al. CANCER RESEARCH
- Fc-fusion proteins: new developments and future perspectives
- (2012) Daniel M. Czajkowsky et al. EMBO Molecular Medicine
- Evaluation of combination therapy schedules of doxorubicin and an acid-sensitive albumin-binding prodrug of doxorubicin in the MIA PaCa-2 pancreatic xenograft model
- (2012) Felix Kratz et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
- (2012) C. F. McDonagh et al. MOLECULAR CANCER THERAPEUTICS
- Albumin-based nanoparticles as potential controlled release drug delivery systems
- (2011) Ahmed O. Elzoghby et al. JOURNAL OF CONTROLLED RELEASE
- Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding
- (2009) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started